Olanzapine
DrugBank ID: DB00334
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 3 |
| DL Only | 47 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| manic bipolar affective disorder | 0.9993 | KG+DL |
| anxiety disorder | 0.9975 | DL |
| bipolar disorder | 0.9955 | DL |
| benign paroxysmal torticollis of infancy | 0.9954 | DL |
| agoraphobia | 0.9947 | DL |
| major affective disorder | 0.9941 | DL |
| schizophrenia | 0.9938 | DL |
| endogenous depression | 0.9928 | KG+DL |
| dysthymic disorder | 0.9928 | DL |
| major depressive disorder | 0.9906 | KG+DL |
| distal 17p13.3 microdeletion syndrome | 0.9897 | DL |
| neurotic disorder | 0.9893 | DL |
| neurotic depression | 0.9877 | DL |
| melancholia | 0.9877 | DL |
| retinal dystrophy with or without extraocular anomalies | 0.9874 | DL |
| Ohdo syndrome and variants | 0.9863 | DL |
| childhood apraxia of speech | 0.9863 | DL |
| unipolar depression | 0.9862 | DL |
| congenital disorder of glycosylation with defective fucosylation | 0.9855 | DL |
| hydranencephaly (disease) | 0.9853 | DL |
| phobic disorder | 0.9846 | DL |
| syndromic myopia | 0.9842 | DL |
| Malan overgrowth syndrome | 0.9841 | DL |
| myopia X-linked | 0.9836 | DL |
| Keppen-Lubinsky syndrome | 0.9835 | DL |
| polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | 0.9834 | DL |
| Charcot-Marie-Tooth disease, demyelinating, type 1G | 0.9831 | DL |
| blepharophimosis - intellectual disability syndrome, Ohdo type | 0.9820 | DL |
| myopia 26, X-linked, female-limited | 0.9810 | DL |
| hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | 0.9787 | DL |
| atypical glycine encephalopathy | 0.9787 | DL |
| surfactant metabolism dysfunction, pulmonary | 0.9772 | DL |
| congenital isolated adrenocorticotropic hormone deficiency (disease) | 0.9766 | DL |
| autosomal dominant slowed nerve conduction velocity | 0.9735 | DL |
| ligneous conjunctivitis | 0.9713 | DL |
| trichotillomania | 0.9704 | DL |
| vitamin B12-responsive methylmalonic acidemia | 0.9687 | DL |
| gaze palsy, familial horizontal, with progressive scoliosis | 0.9658 | DL |
| autism spectrum disorder | 0.9656 | DL |
| Phelan-McDermid syndrome | 0.9632 | DL |
| chromosome 15q26-qter deletion syndrome | 0.9628 | DL |
| mixed anxiety and depressive disorder | 0.9620 | DL |
| asperger syndrome, susceptibility to | 0.9608 | DL |
| autism susceptibility 1 | 0.9534 | DL |
| chromosome 2P16.3 deletion syndrome | 0.9467 | DL |
| Tourette syndrome | 0.9444 | DL |
| Pitt-Hopkins-like syndrome 2 | 0.9341 | DL |
| amelocerebrohypohidrotic syndrome | 0.9290 | DL |
| familial hypertryptophanemia | 0.9286 | DL |
| obsessive-compulsive disorder | 0.9253 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.